Skip to content

Levin Sedran & Berman LLP

Top Rated Philadelphia Law Firm

  • Current Cases
    • UPMC Unfair Labor Practices Lawsuit
    • Social Media Litigation
    • Philips CPAP, BiPAP and Ventilator Devices Recall
    • Talcum Powder
      • Talcum Powder Settlements & Verdicts
    • JUUL Lawsuit
    • Zantac Lawsuit
  • Practice Areas
    • Dangerous Pharmaceuticals
    • Defective Medical Devices
    • Defective Products
    • Personal Injury
    • Antitrust
    • Environment & Toxic Substances
  • Our Firm
    • Attorneys
      • Arnold Levin
      • Howard J. Sedran
      • Laurence S. Berman
      • Frederick S. Longer
      • Daniel C. Levin
      • Charles E. Schaffer
      • Austin B. Cohen
      • Michael M. Weinkowitz
      • Sandra L. Duggan
      • Keith J. Verrier
      • Nicholas J. Elia
      • Zanetta Moore-Driggers
      • Alicia B. Armstrong
    • Leadership
    • History
    • Contact Us
  • News
(877) 882-1011

Levin Sedran & Berman LLP

(877) 882-1011

Menu


  • Current Cases
    • UPMC Unfair Labor Practices Lawsuit
    • Social Media Litigation
    • Philips CPAP, BiPAP and Ventilator Devices Recall
    • Talcum Powder
      • Talcum Powder Settlements & Verdicts
    • JUUL Lawsuit
    • Zantac Lawsuit
  • Practice Areas
    • Dangerous Pharmaceuticals
    • Defective Medical Devices
    • Defective Products
    • Personal Injury
    • Antitrust
    • Environment & Toxic Substances
  • Our Firm
    • Attorneys
      • Arnold Levin
      • Howard J. Sedran
      • Laurence S. Berman
      • Frederick S. Longer
      • Daniel C. Levin
      • Charles E. Schaffer
      • Austin B. Cohen
      • Michael M. Weinkowitz
      • Sandra L. Duggan
      • Keith J. Verrier
      • Nicholas J. Elia
      • Zanetta Moore-Driggers
      • Alicia B. Armstrong
    • Leadership
    • History
    • Contact Us
  • News

FDA Orders Blood Clot Warning for Yaz, Yasmin and Ocella

Posted on October 27, 2011February 16, 2017

The FDA announced that the birth control medications Yaz, Yasmin and Ocella will require an updated warning for a higher risk of blood clots.

Read the Full FDA Announcement Here

Related Posts

  • Yaz/Yasmin Settlement Update
  • FDA Remains Concerned About Blood-Clot Risk with Yaz and Yasmin
  • Current Cases
  • Attorneys
  • Practice Areas
  • Contact Us
  • Our Firm
  • News & Articles
  • Sitemap
Levin Sedran & Berman LLP

Follow Us

Attorney Advertising. This web site is designed for general information only. The information presented at this site should not be construed to be formal legal advice nor the formation of a lawyer/client relationship.